Sign in to view content

Safety Results of ONS-5010, an Ophthalmic Bevacizumab, in Treated Eyes of Patients With Wet AMD, DME, and BRVO

Suber S. Huang, MD, MBA, FASRS

Video
Published 2021

Related

Episode 113: Journal Club, Macular Ischemia in RISE/RIDE, Wet Conversion in AMD, Micropulse for CSR
Jayanth Sridhar, MD
Member Podcasts
2018
Computerized Analysis of Retinal Vascular Growth Following Intravitreal Bevacizumab Monotherapy in Retinopathy of Prematurity Until Three Years of Age
Swati Agarwal-Sinha, MD, FASRS
Annual Meeting Talks
2021
Personalized Treatment Interval Dosing Dynamics Over 2 Years in the Phase 3 YOSEMITE and RHINE Trials of Faricimab in Diabetic Macular Edema
John W. Kitchens, MD
Annual Meeting Talks
2022

Category: Retinal Vascular Disease

See more